ENANTA PHARMACEUTICALS, INC Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31)
ENANTA PHARMACEUTICALS, INC (ENTA) reported Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) of $13.67 million for the 12-month period ending 2013-09-30, per its 10-K filed 2013-12-18.
Discontinued › Notes
us-gaap:UndistributedEarningsAllocatedToParticipatingSecurities · last filed 2014-08-12
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2013-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2013-06-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2013-03-31 was -$5.14M, a 118.25% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for the quarter ending 2012-12-31 was $18.81M.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2013 was $13.67M, a 6.77% decline from fiscal 2012.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2012 was $14.66M, a 9.99% decline from fiscal 2011.
- ENANTA PHARMACEUTICALS, INC undistributed earnings allocated to participating securities (deprecated 2014-01-31) for fiscal 2011 was $16.29M.
| Period end | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 3 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 6 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 9 month | Undistributed Earnings Allocated to Participating Securities (Deprecated 2014-01-31) 12 month |
|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | $0.00 derived: sum of 2 quarters · filed 2014-08-12 | -$5.14M derived: sum of 3 quarters · filed 2014-08-12 | $13.67M 10-K · filed 2013-12-18 |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | -$5.14M derived: sum of 2 quarters · filed 2014-08-12 | $13.67M 10-Q · filed 2014-08-12 | $8.73M derived: sum of 4 quarters · filed 2014-08-12 |
| 2013-03-31 | -$5.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $13.67M 10-Q · filed 2014-05-12 | $8.73M derived: sum of 3 quarters · filed 2014-05-12 | $4.26M derived: sum of 4 quarters · filed 2014-05-12 |
| 2012-12-31 | $18.81M 10-Q · filed 2014-02-13 | $13.86M derived: sum of 2 quarters · filed 2014-02-13 | $9.40M derived: sum of 3 quarters · filed 2014-02-13 | $37.55M derived: sum of 4 quarters · filed 2014-02-13 |
| 2012-09-30 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | -$9.41M derived: sum of 2 quarters · filed 2013-12-18 | $18.74M derived: sum of 3 quarters · filed 2013-12-18 | $14.66M 10-K · filed 2013-12-18 |
| 2012-06-30 | -$4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $23.69M derived: sum of 2 quarters · filed 2013-08-12 | $19.61M 10-Q · filed 2013-08-12 | |
| 2012-03-31 | $28.15M 10-Q · filed 2013-05-15 | $24.07M 10-Q · filed 2013-05-15 | ||
| 2011-09-30 | $16.29M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |